Sign in
4

Changes in Ownership

Hepion Pharmaceuticals, Inc. Filed Acc 0001104659-23-101784

CEO and Director bought 1,600 shares at $5.60 ($8,960)

From the SEC's structured data for this filing

Trades in this filing

Foster Robert T · CEO and Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-18 Purchase : show line 1 in the form +1,600 $5.60 $8,960 50,470 D
Open-market purchases · 1,600 sh · avg $5.60 · $8,960
Loading xslF345X05/tm2326377-1_4seq1.xml…